EUVIMEDEUVIMED entdecken
Crossref

β-Cell–Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion

Frédérik Oger, Cyril Bourouh, Marika Elsa Friano, Emilie Courty, Laure Rolland, Xavier Gromada, Maeva Moreno, Charlène Carney, Nabil Rabhi, Emmanuelle Durand, Souhila Amanzougarene, Lionel Berberian und 14 weitere

Diabetes · 2023

DOI: 10.2337/db22-0604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Frédérik Oger und 25 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, U1283 - UMR8199 - European Genomic Institute for Diabetes (EGID), CNRS, Institut Pasteur de Lille, CHU Lille, Université de Lille, Lille, Fra…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Medical Research Council, Juvenile Diabetes Research Foundation United States of America, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The loss of pancreatic β-cell identity has emerged as an important feature of type 2 diabetes development, but the molecular mechanisms are still elusive. Here, we explore the cell-autonomous role of the cell-cycle regulator and transcription factor E2F1 in the maintenance of β-cell identity, insulin secretion, and glucose homeostasis. We show that the β-cell–specific loss of E2f1 function in mice triggers glucose intolerance associated with defective insulin secretion, altered endocrine cell mass, downregulation of many β-cell genes, and concomitant increase of non–β-cell markers. Mechanistically, epigenomic profiling of the promoters of these non–β-cell upregulated genes identified an enrichment of bivalent H3K4me3/H3K27me3 or H3K27me3 marks. Conversely, promoters of downregulated genes were enriched in active chromatin H3K4me3 and H3K27ac histone marks. We find that specific E2f1 transcriptional, cistromic, and epigenomic signatures are associated with these β-cell dysfunctions, with E2F1 directly regulating several β-cell genes at the chromatin level. Finally, the pharmacological inhibition of E2F transcriptional activity in human islets also impairs insulin secretion and the expression of β-cell identity genes. Our data suggest that E2F1 is critical for maintaining β-cell identity and function through sustained control of β-cell and non–β-cell transcriptional programs. Article Highlights β-Cell–specific E2f1 deficiency in mice impairs glucose tolerance. Loss of E2f1 function alters the ratio of α- to β-cells but does not trigger β-cell conversion into α-cells. Pharmacological inhibition of E2F activity inhibits glucose-stimulated insulin secretion and alters β- and α-cell gene expression in human islets. E2F1 maintains β-cell function and identity through control of transcriptomic and epigenetic programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin-Secreting CellsAnimalsHumansMiceChromatinGlucoseHistonesHomeostasisInsulinInsulin SecretionMice, KnockoutE2F1 Transcription Factor

Substanzen

ChromatinGlucoseHistonesInsulinE2F1 protein, humanE2F1 Transcription FactorE2f1 protein, mouse

Autor:innen und Institutionen

  • INSERM, U1283 - UMR8199 - European Genomic Institute for Diabetes (EGID), CNRS, Institut Pasteur de Lille, CHU Lille, Université de Lille, Lille, France.
  • INSERM, CNRS, Institut de Biologie Valrose, Université Côte d'Azur, Nice, France.
  • INSERM, U1167 - RID-AGE - Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, Institut Pasteur de Lille, CHU Lille, Université de Lille, Lille, France.
  • Department of Biochemistry, Boston University School of Medicine, Boston, MA.
  • Center for Integrative Genomics, Université de Lausanne, Lausanne, Switzerland.
  • UPR CHROME, Université de Nîmes, Nîmes, France.

ORCID-Profile: Lluis Fajas, Philippe Froguel, Jean-Sébastien Annicotte

Förderung

  • Medical Research Council
  • Juvenile Diabetes Research Foundation United States of America
  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale

Zitieren

APA

Oger, F., Bourouh, C., Friano, M. E., Courty, E., Rolland, L., Gromada, X., Moreno, M., Carney, C., Rabhi, N., Durand, E., Amanzougarene, S., Berberian, L., Derhourhi, M., Blanc, E., Hannou, S. A., Denechaud, P. D., Benfodda, Z., Meffre, P., Fajas, L., …, & Annicotte, J. S. (2023). β-Cell–Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion. Diabetes. https://doi.org/10.2337/db22-0604

Vancouver

Oger F, Bourouh C, Friano ME, Courty E, Rolland L, Gromada X, et al. β-Cell–Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion. Diabetes. 2023. doi:10.2337/db22-0604

BibTeX
@article{Oger2023,
  author = {Oger, Frédérik and Bourouh, Cyril and Friano, Marika Elsa and Courty, Emilie and Rolland, Laure and Gromada, Xavier and Moreno, Maeva and Carney, Charlène and Rabhi, Nabil and Durand, Emmanuelle and Amanzougarene, Souhila and Berberian, Lionel and Derhourhi, Mehdi and Blanc, Etienne and Hannou, Sarah Anissa and Denechaud, Pierre-Damien and Benfodda, Zohra and Meffre, Patrick and Fajas, Lluis and Kerr-Conte, Julie and Pattou, François and Froguel, Philippe and Pourcet, Benoit and Bonnefond, Amélie and Collombat, Patrick and Annicotte, Jean-Sébastien},
  title = {β-Cell–Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion},
  journal = {Diabetes},
  year = {2023},
  doi = {10.2337/db22-0604}
}
Kostenlos starten →